近期,百奥赛图在全球创新药产业链上的存在感愈发强烈。进入9月,公司接连发布三项合作消息,涵盖核酸药物递送、ADC研发与双抗ADC合作项目进展,充分展现了其“双业务线”战略的纵深布局与国际竞争力。核酸递送新尝试:携手默克推进抗体偶联LNP在与默克(Merck)的最新合作中,百奥赛图基于RenMice®平台提供全人抗体,默克将评估其在抗体偶联脂质纳米颗粒(LNP)中的应用潜力。LNP是当下核酸药物领域...
Source Link近期,百奥赛图在全球创新药产业链上的存在感愈发强烈。进入9月,公司接连发布三项合作消息,涵盖核酸药物递送、ADC研发与双抗ADC合作项目进展,充分展现了其“双业务线”战略的纵深布局与国际竞争力。核酸递送新尝试:携手默克推进抗体偶联LNP在与默克(Merck)的最新合作中,百奥赛图基于RenMice®平台提供全人抗体,默克将评估其在抗体偶联脂质纳米颗粒(LNP)中的应用潜力。LNP是当下核酸药物领域...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.